🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06863415
Starting soon Not applicable

Study on the Enhancement of Intestinal and Immune Functions Through Probiotic Intervention

NCT06863415 · tracked via the Priya Life Science China tracker
Sponsor
Wecare Probiotics Co., Ltd.
Phase
Not applicable
Started
2025-03-15
Last updated
2025-03-10

Condition(s) studied

Healthy

Investigational drug(s) / intervention(s)

ProbioticPlacebo

Probiotic: Dietary supplement: Probiotics. The trial period of this study lasts for 2 months (8 weeks), during which each participant will have 3 visits (at month 0, month 1, and month 2).

Placebo: Dietary supplement: Placebo. The trial period of this study lasts for 2 months (8 weeks), during which each participant will have 3 visits (at month 0, month 1, and month 2).

Study summary

Evaluate the effectiveness and safety of Bifidobacterium longum subsp. infantis BI45 as a food supplement compared to a placebo in improving intestinal and immune functions in healthy adults.

Eligibility

Sex
ALL
Min age
18 Years
Max age
45 Years
Healthy volunteers
Accepted
Inclusion Criteria: 1. Willing to undergo 3 follow-up visits during the intervention period Be willing to provide blood, urine and stool samples 2 times during the intervention period 2. Willing to self-administer probiotic or placebo once a day during the intervention period 3. Good eyesight, can read and write, can wear glasses 4. Have good hearing and be able to hear and understand all instructions during the intervention Exclusion Criteria: 1. Digestive diseases, mainly gastrointestinal diseases (celiac disease, ulcerative colitis, Crohn's disease) 2. Have a serious neurological condition (epilepsy, stroke, severe head trauma, meningitis in the last 10 years, brain surgery, brain tumor, prolonged coma - not including general anaesthesia) 3. Have received/are receiving treatment for the following mental disorders: alcohol/drug/substance abuse dependence, schizophrenia, psychosis, bipolar disorder 4. Take medication for depression or low mood Internal organ failure (heart, liver or kidney failure, etc.) 5. Have received radiation or chemotherapy in the past 6. Have undergone a general anesthesia procedure/procedure within the past three years, or plan to undergo a general anesthesia procedure/procedure within the next 3 months during this trial period 7. Have had hepatitis (hepatitis B, hepatitis C), HIV or syphilis in the past

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Henan University of Technology Zhengzhou Henan

More Wecare Probiotics Co., Ltd. trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06863415 on ClinicalTrials.gov ↗ ← All trials in China